Syapse enters real-world data collaboration with Merck to inform and improve cancer care
27 October 2021
- The collaboration will leverage real-world data (RWD) to drive high-quality insights that will impact patient care and advance oncology research
- Researchers can learn from real-world clinical, molecular, treatment and outcomes data
- “This work is a true example of what it means to use collaboration to advance the use of RWD and unlock its full potential—the ability to transform patient’s lives.”
Ken Tarkoff, CEO of Syapse
Click here to learn more.
SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.
For more information, please visit www.svmpharma.com and contact us at firstname.lastname@example.org